Rheumatology Advance Access published online on April 27, 2008
Rheumatology, doi:10.1093/rheumatology/ken135
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Autoimmunity manifesting as dermatomyositis associated with oligoastrocytoma and dendritic cell immunotherapy
Centre for Rheumatology, University College Hospitals NHS Foundation Trust, London, UK
Correspondence to:
E. C. Derrett-Smith, UCL-Centre for Rheumatology, Hampstead Campus Royal Free and University College London Medical School, London NW3 2PF, UK. E-mail: e.derrett-smith@medsch.ucl.ac.uk
| The first 10% of the full text of this article appears below. |
SIR, A case of severe dermatomyositis occurring after completion of dendritic cell (DC) immunotherapy as a treatment for grade II oligoastrocytoma is described. This is the first report to our knowledge of dermatomyositis associated with either a primary brain tumour or DC immunotherapy.
A 39-yr-old man presented with a 4-week history of muscle pain and weakness, fatigue, fever and a rash. He had been fit and well, and was a keen athlete until a year prior to this presentation when he had been diagnosed with a grade II oligoastrocytoma. This had been debulked 6 months earlier, with 85% clearance and minimal neurological deficit. No further conventional